SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2: FINAL RESULTS

Fabio Salvatore Macaluso  ¹     Walter Fries  ²     Anna Viola  ²     Andrea Centritto  ²     Maria Cappello  ³     Enrica Giuffrida  ³     ANTONINO CARLO Privitera  ⁴     Giovita Piccillo  ⁴     Antonio Magnano  ⁵     Elisa Vinci  ⁵     Roberto Vassallo  ⁶     Antonino Trovatello  ⁷     Nunzio Belluardo  ⁸     Emiliano Giangreco  ⁸     Salvatore Camilleri  ⁹     Serena Garufi  ⁹     Carmelo Bertolami  ¹⁰     Marco Ventimiglia  ¹⁰     Sara Renna  ¹⁰     Rosalba Orlando  ¹⁰     Giulia Rizzuto  ¹⁰     Ambrogio Orlando  ^10    
1 'Villa Sofia-Cervello' Hospital, Palermo (Pa), Italy
² Inflammatory Bowel Disease Unit, A.O.U. Policlinico, Messina, Italy
³ UOC Gastroenterologia e Epatologia Di.Bi.Mis - University of Palermo, Palermo, Italy
⁴ Inflammatory bowel disease Unit, A.O. 'Cannizzaro”, Catania, Italy
⁵ Gastroenterology Unit, A.O.U. Policlinico “Vittorio Emanuele”, Catania, Italy
⁶ Gastroenterology and Endoscopy Unit, A.O. “Buccheri La Ferla Fatebenefratelli”, Palermo, Italy
⁷ Surgery Unit, A.O. “Umberto I”, Siracusa, Italy
⁸ Gastroenterology Unit, A.O. “Guzzardi”, Vittoria, Italy
⁹ Gastroenterology Unit, A.O.O.R. “S. Elia- M. Raimondi”, Caltanissetta, Italy
¹⁰ Gastroenterology Unit, A.O.O.R. “Papardo Piemonte”, Messina, Italy

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)